navgun281
Posted - 14 hours ago
$IVVD buy more Monday
Nik_CA
Posted - 20 hours ago
$IVVD PTs by 5 analysts seems to be multiple X from the current SP. How soon do we see it run is anybody's guess?
Nik_CA
Posted - 20 hours ago
$IVVD Interesting numbers for the short shares availability. It appears someone knows something about P3 expected to be completed this month. See my previous post for the estimated study completion date.
Nik_CA
Posted - 20 hours ago
$IVVD Phase 3 of VYD222 (pemivibart) is estimated to end in Nov 2024. It remains to be seen if it is followed with a full FDA approval for pemivibart or would CT for VYD2311 will be expedited.
Nik_CA
Posted - 20 hours ago
$IVVD Study completion pf Phase 1 for VYD2311 is May 2025. The enrollment is bumped up from 30 to 40 participants. This is consistently in line with my expectations to see a strong movement during summer 2025.
sintaka
Posted - 1 day ago
$IVVD Can it be revived?
Nik_CA
Posted - 4 days ago
$IVVD This is no longer a risk. https://stocktwits.com/Nik_CA/message/593121799
Nik_CA
Posted - 4 days ago
$IVVD A must read for retail SHs to understand why Q3 revenue was lower than expected. Since the Ho Lab's inaccurate report is replaced by the validated pemivibart KP.3.1.1 neutralization data from Labcorp-Monogram Biosciences (Monogram) in September 2024, the PEMGARDA Fact Sheet continues to accurately reflect the neutralization activity of PEMGARDA (pemivibart) against KP.3.1.1. This implies that the revenue should pick up some steam. https://www.stocktitan.net/news/IVVD/invivyd-announces-new-england-journal-of-medicine-publishes-letter-i7qblavulu8q.html
GakiYoui_Atsu
Posted - 6 days ago
$WIMI Sick Bear trap at the open Bear falling for it every time $IVVD $QCOM
SamGantVHee
Posted - 1 week ago
$IVVD buy
LionEagle
Posted - 1 week ago
$PACB most bios are down due to the Trump trade. The entire market is coming back to its mean, which it should, from the election spike. I jumped back into PACB a few mins ago for a position trade. My other bios are down ($DDD $QSI $CERS $IVVD) and I have no intention on selling. By the way, someone said below that Cathie shorted this. She does not short and no smart fund manager would risk their entire portfolio over a $2 short gain with unlimited upside potential. With all the bios down, it's a good time to pick up more of your favs.
ZACHSPIZZA
Posted - 1 week ago
$IVVD Jesus
d_risk
Posted - 1 week ago
$IVVD - Invivyd Inc. Common Stock - 10Q - Updated Risk Factors Invivyd's risk factors now stress the impact of third-party lab data on product candidates, affecting regulatory approval and market acceptance, with recent FDA updates on PEMGARDA underscoring these concerns. #Risk @Invivyd https://d-risk.ai/IVVD/10-Q/2024-11-14
VernonTasi
Posted - 1 week ago
$IVVD What would be projected revenue for coming three quarters : Q4'24 - 20m Q1'25 - 40m Q2'25 - 80m Their current Loss per quarter is 60m and that is equivalent to 60x4 =240m. To get to profitability , revenue should be more than 60m per quarter and they expect that to happen H1 , which means they reach their revenue by H1. That is even a daunting target at this time. SP would be volatile though recover over time. There would be zero surprise. Hence, short term is bearish.
Nik_CA
Posted - 1 week ago
$IVVD Ivvd PR is inline with my projections
“Targets near-term (1H 2025) profitability with existing cash and cash equivalents, anticipated growth of net product revenue, and various operational efficiency improvements”.
Whether they can reach it is to be seen.😀
Nik_CA
Posted - 1 week ago
$IVVD Also, there’s another catalyst to watch for by EOY.
“Next generation molecule VYD2311 first-in-human clinical trial dosing began in August 2024 with anticipated preliminary data readout late Q4 2024”.
alexx013
Posted - 1 week ago
$IVVD added @ .90
ZACHSPIZZA
Posted - 1 week ago
$IVVD this turd. My second biggest unrealized loser thus far. Haven’t added again as floor is not confirmed. Waiting
VXRT007
Posted - 1 week ago
$IVVD new PR today, not sure what that will do for the SP
solidstate32
Posted - 2 weeks ago
$IVVD
TWITLIEDETECTOR
Posted - 3 weeks ago
$IVVD in case you are not following along. 13 key account manager openings and 1 strategic account manager director
DonCorleone77
Posted - 3 weeks ago
$AZN $KYMR $VIR $ALNY $IVVD U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says U.S. drugmakers and biotechs rely on Chinese partners for manufacturing, research, and ingredients, but, with geopolitical tensions rising, companies are now looking for alternatives, Jared Hopkins and Clarence Leong of The Wall Street Journal reports. Pharmaceutical and biotechnology companies of all side are saying it's time to reduce China risk. Industry officials, however, note one consequence of this move may be slower drug rollouts and higher costs in the U.S. Companies making this move include AstraZeneca (AZN), Kymera Therapeutics (KYMR), Amicus Therapeutics (FOLD), Vir Biotechnology (VIR), Alnylam Pharmaceuticals (ALNY), Invivyd (IVVD).
v5asi12345
Posted - 10/31/24
$IVVD Shorts are active but scared.. This is not going to zero.
Serious_Hex_Est2020
Posted - 10/30/24
$IVVD $BA $WIMI
Marianirl
Posted - 10/30/24
$WIMI Investing is a lot like fishing, you can't guarantee that you will catch a fish after you cast your rod, so make sure you take every investment seriously $IVVD $BA
GakiYoui_Atsu
Posted - 10/30/24
Here's the list of stocks I bullish on 1. $META 2. $MU 3. $TSLA 4. $WIMI 5. $IVVD
Marianirl
Posted - 10/29/24
$WIMI messy market is good learning environment u get to learn both the bulls and bears $IVVD $AMC
I_saw_the_kraken
Posted - 10/29/24
$IVVD may someone give me some context about the company? Why did Morgan Stanley and H.C. Wainwright gave yesterday a price of $9,50 and $15 to this stock? Is this actually cooking something?
alexx013
Posted - 10/29/24
$IVVD buying more here @ .91